Jump to content

Talk:COVID-19 vaccination in the United Kingdom

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Smjg (talk | contribs) at 14:41, 21 July 2021 (Actual Protection). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

How to expand the lead

As part of page curation, a hatnote (or maintenance tag) has been added to the page alerting us to an issue with the brevity of the lead and that it may not adequately summarise the rest of the article. It's not immediately obvious how the lead should be expanded. I thought we could start a discussion here as to how best to do this. Looking at the other sections and subsections, it will not be easy to summarise the information. I was wondering whether more of an overview should be taken where something could be said about the different bodies involved in vaccine deployment. It can't all just fall under the auspices of Minister for COVID Vaccine Deployment, it seems to draw from a number of places, including Public Health England. There's also an issue of ensuring that the lead reflects the whole of the UK, and not just the relevant bodies in England.

The MHRA are much more involved than they may seem, also I believe NIBSC to be involved in initial batch testing: "The National Institute for Biological Standards and Control, part of the agency, has been and will continue doing, independent laboratory testing so that every batch of the vaccine meets the expected standards of safety and quality."[1]. NIBSC are also involved in testing coronavirus vaccines globally, but this is not as relevant. [2]

Also, there's the Vaccine Taskforce (UK) which are also involved, in a more overarching way. This article in The Guardian provides a perspective from the UK Vaccine Taskforce and states the following: "NHS England and NHS Improvement (NHSE&I) and Public Health England are leading on the operational delivery of the vaccination programme in England."[3] These details might help expand the lead by writing a few sentences about the various bodies involved. There are clearly more moving parts than first meets the eye. The article mentions the Joint Committee on Vaccination and Immunisation further down the page, but they should perhaps be mentioned in the lead too. This PDF contains a lot of useful information, some of it slightly out-of-date though.[4]

The BMA also appear to be involved with what they term "CVP" (COVID-19 vaccination programme) in England.[5][6][7] This group letter from NHS (Skipton House) also sheds light on the 3 defined deployment models as at 20 November 2020 and also gives two key names: Emily Lawson, Chief Commercial Officer and SRO for Covid-19 Vaccine Deployment NHS England and NHS Improvement; and Sue Harriman, Chief Operating Officer Covid-19 Vaccination Deployment Programme.[8] I hope these links help in some way to produce more of an overview of the bodies involved. SpookiePuppy (talk) 20:23, 20 December 2020 (UTC)[reply]

@SpookiePuppy: Sorry, didn't see this before I have made the first attempt of re-writting the lead see here. Many thanks for your many insights and I am happy to bow to consensus of better wording! P.S. I have removed the tag, I can put it back on if not properly resolved yet? Thanks. --Crep1711 (talk) 21:28, 20 December 2020 (UTC)[reply]

References

Roll-out numbers

These are quoted form the press but my calculations are about 28 million for the 1st phase (vs. 30m in the table). While my estimate may be wrong also, I suspect there is a double count of 1.5 to 2 million. The source clearly did not allow for people appearing in more than one category, as the age group data matches the ONS data exactly. Wayne (talk) 13:42, 4 January 2021 (UTC)[reply]

Many thanks @Wayne: for raising this and for this edit on the article in an attempt to clarify. I have been thinking about this too as I spotted this alternative metric from the BBC (as it is freely accessible rather than a subscription source). However, the figures do vary, especially the 16-64 underlying health conditions row. I was half hoping the government may publish some sort of commissioned study. However, what do others think? If this is such a grey area, maybe we shouldn't go down the speculative numbers route? Or a simpler disclaimer, as per the BBC source, underneath the table? Do more editors have suggestions? Thanks. --Crep1711 (talk) 18:15, 4 January 2021 (UTC)[reply]
I had added a disclaimer in the text above - could put it below. Wayne (talk) 16:38, 7 January 2021 (UTC)[reply]

New government document: UK COVID-19 vaccines delivery plan

Lots of information in this new government document, published yesterday, 11 January. MichaelMaggs (talk) 10:34, 12 January 2021 (UTC)[reply]

Many thanks @MichaelMaggs: most appreciated. I haven't had a chance to go through it yet but will do so soon. In fact there are loads of different snippets of info / updates I want to do but struggling for time to keep up. Hope, perhaps, to have a bit of a blitz soon. Many thanks for your continued support. --Crep1711 (talk) 08:53, 13 January 2021 (UTC)[reply]

Phase 2 info out of date?

It seems the plan has changed. This BBC News article tells us the new plan is that Phase 2 will be age groups 40-49, 30-39 and 18-29 in that order. This has been reflected on Omni Calculator. However, I can't seem to find anything about the new plan on gov.uk.... — Smjg (talk) 13:39, 1 March 2021 (UTC)[reply]

I've updated it using the JCVI interim report. ArcMachaon (talk) 23:12, 8 March 2021 (UTC)[reply]

Kate Bingham sets out UK vaccine approach

This is a useful article where Kate Bingham discusses the UK vaccine procurement etc. Might be useful for this page. https://www.repubblica.it/cronaca/2021/02/07/news/kate_bingham_interview_vaccines_covid_astrazeneca_uk_coronavirus_johnson-286384093/ Jopal22 (talk) 18:43, 4 March 2021 (UTC)[reply]

Adult population vs. actual population

I've noticed that every other country pretty much measures percentage based on the total population of the country, yet you have the adult population listed. I attempted to change this in an edit a while ago but it was reverted. I think some discussion should be generated about this. CaffeinAddict (talk) 04:45, 7 May 2021 (UTC)[reply]

I believe by default most countries pages are doing based upon total population, since it's easier to calculate. I changed this because the vaccine is not approved for children, it would not be a useful metric at all to have a total population number used for vaccines if anyone below 16 is unable to get them it would give a distorted picture of the programme. Also, the doses reported and percentages should match the government figures, which they wouldn't if total population is included (specifically the percentages). Personally, I would keep it like this until the vaccine is approved for adolescents etc, but there should be some more voices on here before any more decisions made. Haroony213 (talk) 12:36, 8 May 2021 (UTC)[reply]
Vaccines are approved for people aged 16+. The gov.uk page gives the percentage of people aged 18+ who have had first and second doses. In my view, what we really should be giving is the percentage complete the vaccination programme is. If I'm not mistaken, this is the UK's COVID-19 vaccination programme, not the UK's COVID-19 adult vaccination programme specifically, and as such all ages would naturally be offered the jab once vaccines are approved for them. Therefore, the percentage complete would be the percentage of the total population who have had the jab (or explicitly declined to have it; this is before you consider people deemed medically unfit, which would open a new can of worms). However, it seems we don't have the required data to do this – see my comment below – and so the best we can do is just show the percentages given on the gov.uk page, which are percentages of adults who have been vaccinated. — Smjg (talk) 11:36, 12 May 2021 (UTC)[reply]

Currently, the percentage figures in the infobox are being done as calculations. There are three problems with this:

  • The percentages are being given as percentages of adults who have been vaccinated, but they're being calculated using the total numbers of first and second doses given, which count children (at the moment, these are 16- and 17-year-olds classed as clinically vulnerable, plus any under 16s given a vaccine as exceptional cases if there are any) and adults alike.
  • Where is the total size of the adult population being taken from, and how is this being kept up to date? Looking at the page history, it would appear the answer to the latter question is "it isn't". People are reaching adult age every day, and people are dying every day (and not just from COVID). (In normal circumstances, there'd also be migrations to consider.)
  • Even if we had up-to-date figures for both of these which count only the adults, we would still need to exclude from the counts those who have had one or both doses and since died, but we don't seem to have any figures for this.

As such, we don't have the necessary data to do calculations for this. As such, I'm going to amend it to just give the percentages from the government page. — Smjg (talk) 11:16, 12 May 2021 (UTC)[reply]

I agree with the points, for the fact that some 16-17 and children may be vaccinated, I agree it is just simpler to use GOV.uk percentages. I was the one who changed it from total population to adult, and the formula for percentage was already there, I essentially revered the percentages given by the GOV.uk ones to get an adult base population number and used that as what to divide by in the formula. In retrospect, I should've just presented what's on GOV.uk instead of calculating. One point I would raise is that only the Pfizer vaccine is approved for over 16s (thereby being the only given to 16/17 so not all are like you said), and, the current target of the programme is to vaccinate adults and a few children (16s/17s and younger special cases), when the vaccine is approved for younger people, we should change accordingly. But the current target is the immunisation of adults (mainly). If we're looking really long term, yeah sure, it is the COVID-19 immunisation programme in the UK for everyone.

If its worth anything, the percentage that was calculated before you changed it matched the GOV.uk dashboard, but would be rounded up/down by default, but mostly matched the dashboard when I updated it. Haroony213 (talk) 03:02, 13 May 2021 (UTC)[reply]

Just touching base on the discussion I generated here. Because Deployment of COVID-19 vaccines calculates percentage of total population, it seems to make sense in a worldview of the subject rather than the UK only view. For the record, I'm Canadian and started the COVID-19 vaccination in Canada article. We've recently approved the use of Pfizer for people as young as 12. With exception of a few local metrics (for example the City of Toronto), most of our sources don't calculate percentage of adult population vaccinated (and when they do they include the general population as well). But these are skewed now because it counts adults as 18+ when we are now beginning to vaccinate 12+. I think in the grand scheme of things it is a better metric to calculate total population as it is likely that the UK will follow suit and approve vaccine for children as well. Anyway that's my two cents. CaffeinAddict (talk) 17:01, 18 May 2021 (UTC)[reply]

I had concerns immediately I came to the article that it is using percentages that are the adult population not the total population. Given that the total numbers that have been vaccinated are the totals and that people might think of the total population of the UK as being around 65 million, the use of the percentages by reference to adults only is a misleading exaggeration that, even though it states "adult population" tends to suggest it has been rolled out - in the sense of people actually being given vaccinations - more than it has. I even feel I have to clarify, when I use the word "people" these days, that "people" includes children since they are routinely excluded from the Government's figures. It is even affecting debate in the UK in that it is being claimed that 83% of the population have had a first dose, when in fact it is much lower since there are millions of unvaccinated children. As regards the vaccine "not being approved for children", this is no longer true. The Pfizer-BioNTech vaccine has been approved for use in older children in the UK. Nor do I find at all convincing an argument that the total population wouldn't be an appropriate when the vaccine hasn't been approved for children under 12 or, since the Government hasn't decided, based on vaccination committee recommendation, to vaccine (older) children that therefore the adult population should be used because children haven't been vaccinated. On the contrary, *because* children have *not* been vaccinated, the population used should therefore *not* be the adult population. Using the adult population is precisely wrong when children have not been vaccinated, are therefore excluded from vaccination at present, because it therefore presents a misleading picture as to the extent of the vaccination. It suggests 83% have been vaccinated when in fact children have been excluded because they are not included in the programme. Therefore, the use of the adult population gives a distorted picture, the precise opposite of the argument proposed above. Neither does the use of the adult population, when total populations would normally be used when talking about percentages in a country, be a neutral point of view. Children do exist in the UK and in a not insignificant number and moreover I understood that the percentages needed to achieve vaccine-induced immunity are of the total population not the adult population only so seeing 83%, people could be misled that the UK is much closer to reaching a maybe 90% herd immunity for the Delta variant present there than is in fact the case. Use of the adult population is not neutral point of view and instead it is biased, and especially when the adults-only percentages are coming from the biased source of the UK Government, which is not objective or neutral but is a biased and politically motivated source using figures that support its own vaccination programme. I note I am not the only one who has had concerns over use of the adult population. The article's use of the adult population also undermines my trust in Wikipedia since I see Wikipedia as politically biased and politically motivated by using such slanted figures that support the politically motivated UK Government's narrative aspaa (talk) 20:05, 27 June 2021 (UTC)[reply]

Doses actually delivered

It seems to be difficult to obtain the breakdown by vaccine type delivered. I have to say, I'm getting mighty tired of the false equivalence of "fully vaccinated". Each vaccine has a different effectiveness level against different COVID strains, depending upon dosage history and time elapsed.

We're going to need to take a far more nuanced view of this going forward—refracted through final vaccine uptake, down to the granularity of major subpopulations—to see where the cookie crumbles on "openness" for different countries and regions.

Right now, ten minutes of focused Google search did not determine the ratio of Pfizer to AZ shots delivered in the UK to my satisfaction. What I seemed to discover is that at some recent point in time, actual deliveries from the drug companies were 2:1 in favour of AZ of Pfizer (this only loosely correlates over short spans of time with jabs delivered to the population).

Here on Wikipedia, this article fails to moot that this distinction is important, as it rushes to tabulate "one" against "two" in glorious technicolor. 50% worthless, as I happen to believe that one dose of Pfizer (or the mRNA twins more generally) might be as effective as two doses of another vaccine, depending upon the strain in circulation, and the health status (mainly age) of the recipient.

In the UK, the 617 variant is now on the upswing, as a first-dose coverage rate about the same as Canada. But I'm not sure this will happen in Canada, where one dose of Pfizer is the norm by far, despite the UK's vast superiority in 2nd doses delivered. 617 is the main lingering threat to whether Western society is mostly open for business as usual come the autumn, or hunkering down to avert yet another wave, as some booster shot of slightly different composition is hastily brewed for rapid deployment.

We need to stop pretending that all vaccines are created equal PDQ, if we're going to track this development with any cognitive nuance moving forward from our present circumstance in early summer. — MaxEnt 18:17, 1 June 2021 (UTC)[reply]

Actual Protection

The actual effectiveness of the Covid-19 vaccination can be found in the Yellow books.

The following are the total number in the UK people who have had Covid-19 whilst vaccinated. For both Pfizer and AstraZeneca the numbers are very low. It also does not take into account the total number of people vaccinated with each type of vaccine, the health or age of the vaccinated, the number of vaccines taken or the period of time after being vaccinated. It is also possible for one person to have more than one reaction.

Should this be included in the main page?

Caption: Coronavirus (COVID-19) vaccine adverse reactions - Fatality with vaccine by type
2021-06-09 2021-06-14 2021-06-23 2021-07-07
Reaction Name Pfizer AstraZeneca Pfizer AstraZeneca Pfizer AstraZeneca Pfizer AstraZeneca
COVID-19 32 23 32 23 32 23 33 23
COVID-19 pneumonia 12 7 12 7 13 9 13 9
Suspected COVID-19 1 0 1 0 1 0 1 0
Total 45 30 45 30 46 32 47 32


Caption: Coronavirus (COVID-19) vaccine adverse reactions - Cases with vaccine by type
2021-06-09 2021-06-14 2021-06-23 2021-07-07
Reaction Name Pfizer AstraZeneca Pfizer AstraZeneca Pfizer AstraZeneca Pfizer AstraZeneca
Asymptomatic COVID-19 10 4 10 4 10 4 11 4
COVID-19 670 431 681 437 708 474 749 529
COVID-19 pneumonia 26 25 26 25 33 32 34 32
Coronavirus infection 6 4 6 4 6 4 6 5
Post-acute COVID-19 syndrome 0 4 0 4 0 4 1 4
Severe acute respiratory syndrome 1 5 1 5 1 5 1 5
Suspected COVID-19 38 36 38 36 41 37 44 40
Total 751 509 762 515 799 560 846 619

--AncientArk (talk) 09:48, 21 June 2021 (UTC)[reply]

@AncientArk: I'm confused. You state "The following are the total number in the UK people who have had Covid-19 whilst vaccinated" but the table headers indicate that they are numbers of people who've had COVID-19 as a reaction to the vaccine, which is totally different. I've just taken a quick look at one of the documents on gov.uk that you've linked to and it seems it's different again: numbers of people who've had COVID-19 where the reporter has suspected that the vaccine caused it. On this basis, it seems we can't use these figures to tell us how effective the vaccines are. I think that, in the majority of cases, there would be no reason to suspect that the vaccine caused the disease - one would presume the vaccine merely failed to prevent it.
A further consideration is that being vaccinated is going to alter people's behaviour. These behavioural changes will affect their chances of coming into contact with somebody with COVID-19 and therefore catching the infection. Therefore, such figures cannot be relied on to measure vaccine efficacy unless they are from blinded, placebo-controlled trials. — Smjg (talk) 14:41, 21 July 2021 (UTC)[reply]

Weekly Figures Table

The article includes a weekly figures table which runs to 21 March 2021. I feel this either needs to be

a) removed from the article b) brought up to date, or c) replaced with a more useful graphic of vaccine figures

Currently it's just incomplete information. I'm not sure it actually adds very much to the article so would appreciate thoughts on this.

Thanks — Preceding unsigned comment added by Tracland (talkcontribs) 06:14, 25 June 2021 (UTC)[reply]